On the public citation graph

Powerful Ideas for Global Access to Medicines

https://doi.org/10.1056/nejmp1613861
0 signed · 24 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.healthpol.2010.12.002openalex-snapshot
The cost of drug development: A systematic review
inferredcites →https://doi.org/10.1038/536388aopenalex-snapshot
Busting the billion-dollar myth: how to slash the cost of drug development

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3575824openalex-extracted
COVID-19: Insights from Innovation Economists
inferred← citeshttps://doi.org/10.1007/978-3-031-48991-4_5openalex-snapshot
Challenges and Future Directions of Palliative Care Globally
inferred← citeshttps://doi.org/10.1007/978-3-319-31738-0_5-1openalex-snapshot
Challenges and Future Directions of Palliative Care
inferred← citeshttps://doi.org/10.1007/978-3-319-31738-0_5-2openalex-snapshot
Challenges and Future Directions of Palliative Care Globally
inferred← citeshttps://doi.org/10.1007/978-3-319-77740-5_5openalex-snapshot
Challenges and Future Directions of Palliative Care
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2024.101262openalex-snapshot
Exploring access to essential medicines in the South Pacific: insights from a multi-country cross-sectional study
inferred← citeshttps://doi.org/10.1017/9781009746274.015openalex-snapshot
Paying for medicines
inferred← citeshttps://doi.org/10.1017/9781108659802.011openalex-snapshot
“Thou Shalt Not Steal”: The Morality of Compulsory Licensing of Pharmaceutical Patents
inferred← citeshttps://doi.org/10.1057/s41599-024-03452-0openalex-snapshot
Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem
inferred← citeshttps://doi.org/10.1093/scipol/scaa028openalex-snapshot
COVID-19: Insights from innovation economists
inferred← citeshttps://doi.org/10.1111/dme.13947openalex-snapshot
A perspective on global access to insulin: a descriptive study of the market, trade flows and prices
inferred← citeshttps://doi.org/10.1186/s40854-022-00388-9openalex-snapshot
An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding
inferred← citeshttps://doi.org/10.1634/theoncologist.2017-0671openalex-snapshot
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust
inferred← citeshttps://doi.org/10.21201/2017.0780openalex-snapshot
High-Priced Medicines and Lack of Needs-Driven Innovation: A global crisis that fuels inequality
inferred← citeshttps://doi.org/10.23889/suthesis.55173openalex-snapshot
Bridging the gap between the distinct regulatory frameworks of international trade law and UN human rights law: Access to medicines
inferred← citeshttps://doi.org/10.31080/asms.2019.03.0420openalex-snapshot
Theory of Change: An Approach to Improve Access to Medicines in Low and Middle-Income Economies
inferred← citeshttps://doi.org/10.31235/osf.io/65pgropenalex-snapshot
COVID-19: Insights from Innovation Economists (with French executive summary)
inferred← citeshttps://doi.org/10.31235/osf.io/b5zaeopenalex-snapshot
COVID-19_Insights from Innovation Economists
inferred← citeshttps://doi.org/10.31248/jdps2019.025openalex-snapshot
Affordability issues of biotech drugs in low- and middle-income countries
inferred← citeshttps://doi.org/10.33552/abeb.2019.02.000538openalex-snapshot
Cost of Biotech Drug Development and Affordability Issues in LMICs
inferred← citeshttps://doi.org/10.3389/fmed.2017.00218openalex-snapshot
Innovative Approaches to Increase Access to Medicines in Developing Countries
inferred← citeshttps://doi.org/10.36346/sarjps.2019.v01i02.001openalex-snapshot
Affordability Issues Of Biotech Drugs In Low- And Middle-Income Countries (Lmics)- Short Communication
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.